Mitapivat

Mitapivat (CAS No.: 1260075-17-9) is a synthetic small molecule pyruvate kinase activator broadly classified as a metabolic pathway modulator for life sciences research, with primary application in erythrocyte metabolism and glycolysis focused drug discovery workflows, and it is widely characterized as an allosteric activator of pyruvate kinase isoforms associated with PKLR and PKM2 biology, where target engagement is linked to enhanced pyruvate kinase catalytic function, improved enzyme conformational stability, and increased cellular ATP production that supports restoration of glycolytic flux in deficient or metabolically stressed experimental systems; in mechanistic studies, its activity is commonly interpreted through pyruvate kinase dependent control of phosphoenolpyruvate to pyruvate conversion and downstream effects on cellular energy balance and metabolic signaling networks connected to redox homeostasis and biosynthetic adaptation, while reported pharmacology in biochemical and cell based assays is generally described within nanomolar to micromolar concentration ranges depending on assay format, isoform context, and model background; accordingly, this compound is frequently used in in vitro enzyme assays, genetically defined cell models, and translational preclinical research paradigms to interrogate pyruvate kinase regulation, validate metabolic vulnerabilities, and support hit to lead or mechanism informed screening strategies, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.